Abbott Laboratories vs. Aquestive Therapeutics, Inc. Common Stock
ABT
Abbott Laboratories
$116.64 +2.19%
VS AQSTAquestive Therapeutics, Inc. Common Stock
$4.66 +3.67%
Abbott Laboratories (ABT) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| ABT | AQST | |
|---|---|---|
| Market Cap | $201.83 billion | $584.88 million |
| Revenue (TTM) | $46.59 billion | $54.09 million |
| Net Income (TTM) | $5.42 billion | $-78,227,000 |
ABT leads on 3 of 3 size & scale factors.
Valuation
| ABT | AQST | |
|---|---|---|
| P/E Ratio | 37.75 | — |
| Price / Book | 3.90 | -10.34 |
| Price / Sales | 4.33 | 10.81 |
ABT and AQST split the valuation factors evenly.
Profitability
| ABT | AQST | |
|---|---|---|
| Net Margin | 11.65% | -144.63% |
| Return on Equity | 10.48% | 138.24% |
ABT and AQST split the profitability factors evenly.
Dividend
| ABT | AQST | |
|---|---|---|
| Dividend Yield | 2.16% | — |
| Payout Ratio | 81.55 | — |
ABT and AQST split the dividend factors evenly.
Risk & Sentiment
| ABT | AQST | |
|---|---|---|
| Short Interest | 0.57% | 0.00% |
AQST leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, AQST overview, AQST financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.